西班牙Certest人血紅蛋白蛋白質（天然提取物）

廣州健侖生物科技有限公司

廣州健侖長期供應各種生物原料，主要代理品牌：西班牙Certest。

主要產品包括各種生物單克隆抗原抗體、重組蛋白。

西班牙Certest人血紅蛋白蛋白質（天然提取物）

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

歡迎咨詢

歡迎咨詢2042552662

【產品介紹】

西班牙Certest人血紅蛋白蛋白質（天然提取物）

方法技術從來都是科學進步的推動力，三位獲獎者的研究成果發展出了多項納米顯微技術，目前已被世界各地廣泛使用。功能強大的納米顯微鏡所展示的微小世界，也產生了很多前沿認知。斯特凡·黑爾看到了活神經細胞的內部，這能幫助更好地理解大腦突觸;威廉·莫納研究了與亨廷頓氏病相關的蛋白質;而埃里克·貝齊格對胚胎中的細胞分裂進行了跟蹤。類似的例子不勝枚舉。毫無疑問，2014年諾貝爾化學獎得主們所作出的成就，將對*的福祉作出重大貢獻。
研究人員在干細胞成為血液細胞的過程中(該過程稱為造血作用)，發現以前未被發現的步驟。一個研究組，包括溫斯洛普教授溫迪·埃伯，已經建立了一個非常復雜的一系列事件確定血液祖細胞群密切相關的命運。
埃伯教授，這項研究的一個共同作者，是西澳大利亞州大學病理學和實驗室醫學學院的負責人。
這項研究，是大型藍圖研究項目中用于了解血液疾病的一部分，識別血液細胞類型之間的基因表達的成千上萬的差異。這些差異導致了許多特定事件，這些事件在血液正常發育中起著至關重要的作用。在這個過程中出錯可能會導致血液疾病，包括白血病。相關文章發表于2014年9月26日的《Science》雜志上。
*生成轉錄因子和其他蛋白質調控這個復雜過程的綜合目錄。這項研究發現，RNA在造血過程中以不同的方式被剪切并粘貼到一起，導致每一個階段的蛋白特定形式。直至本研究，血細胞生成在DNA的水平上有了比較充分的了解。不知道的是，然后DNA上的遺傳信息是如何轉錄生成RNA，導致蛋白的形成。、
“我們已經確定了上千個新的RNA被另一種方式處理的位點，” 劍橋大學實驗血液學和威康信托基金會桑格研究所的教授Willem Ouwehand說。在血細胞發育的RNA的可變剪接的關鍵重要性是，通過研究兩種不同形式的同種轉錄因子在巨核細胞(血小板的的前體細胞)形成中的作用來說明的。
埃伯教授說：“這樣的事件改變了來源于單一基因的蛋白質的數量，結構和行為。替代蛋白可促進干細胞轉化為不同的成熟血細胞。”
這項研究所需的造血干細胞和其他細胞沒有被先前的人們研究的很詳細，是因為它們在成人的骨髓中極為罕見。埃伯教授說：“在這項研究中，我們能夠從捐贈的臍帶血中純化出這些細胞，這些祖細胞在臍帶血中的濃度高得驚人。”

西班牙Certest人血紅蛋白蛋白質（天然提取物）

想了解更多的產品及服務請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室

Methodology has always been the driving force of scientific progress, the three winners of the research results developed a number of nano-microscopy, has been widely used around the world. The tiny world displayed by powerful nano-microscopes also generates a lot of cutting-edge awareness. Stefan Hale sees the inside of living nerve cells, which helps to better understand brain synapses; William Mona studied proteins associated with Huntington's disease; and Eric Bezig on embryos The cell division was followed. There are many similar examples. Undoubtedly, the achievements made by 2014 Nobel Laureates in Chemistry will make a significant contribution to the well-being of all humanity.
Researchers in the stem cells into blood cells (the process known as hematopoietic), found that previously undiscovered steps. An international study group, including Wendy Eppe, of Winthrop, has established a very complex series of events that determine the fate of closely related blood progenitor populations.
Professor Eber, co-author of the study, is the head of Western Australia's College of Pathology and Laboratory Medicine.
This study, which is part of a large international blueprint research project used to understand blood diseases, identifies thousands of differences in gene expression between blood cell types. These differences lead to a number of specific events that play a crucial role in the normal development of blood. Errors in the process can lead to blood diseases, including leukemia. A related article was published in the September 26, 2014 issue of Science.
For the first time a comprehensive list of transcription factors and other protein-regulated complex processes is generated. The study found that RNA is sheared and pasted together in different ways during hematopoiesis, resulting in a protein-specific form of each stage. Up to this study, hematopoiesis was well understood at the DNA level. I do not know is how the genetic information on the DNA is then transcribed into RNA, leading to the formation of the protein. ,
"We have identified thousands of new RNAs that are treated differently by another approach," said Willem Ouwehand, a professor of experimental hematology at the University of Cambridge and the Sanger Institute of Wellcome Trust. The crucial importance of alternative splicing of RNA in blood cell development is illustrated by studying the role of two different forms of the same transcription factor in the formation of megakaryocytes (plaet precursors).
Professor Eber said: "Such events change the number, structure and behavior of proteins that originate from a single gene, and alternative proteins can promote the conversion of stem cells into different mature blood cells."
The hematopoietic stem cells and other cells needed for this study have not been studied in great detail by previous studies because they are extremely rare in adult bone marrow. Professor Eber said: "In this study, we were able to purify these cells from donated umbilical cord blood. The progenitor cells were unusually high in umbilical cord blood."